foxo4 dri senolytic peptide study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI 10mg | Senolytic Research
FOXO4 DRI 10mg Senolytic Research Peptide Kalyx Labs FOXO4 DRI 10mg D Retro Inverso PPI Peptide VPeptide FOXO4 DRI Canada: Ultra Pure Peptide for Senolytic, Cellular Aging & Longevity Pathway Research The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI Dosing: 1mg Senolytic Protocol (2026) FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology
Pay in 4 interest-free payments of $6.79 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21




